Abstract |
Aclacinomycin (ACR) is an anthracycline anticancer drug that shows marked effects in Adriamycin (ADM)-resistant tumors. ADM, however, is not effective against ACR-resistant tumor cells. When tumor cells acquire resistance to ACR, though the resistance is not easily acquired, they show strong cross-resistance to ADM. To study the mechanism underlying these phenomena, we studied the resistance mechanism of ACR- and ADM-resistant P388 leukemia cells. The P388/ACR cells showed 4.9- and 100-fold resistance to ACR and ADM, respectively, whereas the P388/ADM cells showed respectively 2.0- and 270-fold resistance. Both P388/ACR and P388/ADM cells expressed large amounts of P-glycoprotein, and the amount was 3-fold higher in the P388/ACR than in the P388/ADM cells. As a result, the accumulation of vincristine and ADM were greatly reduced in P388/ACR and P388/ADM cells, as compared with the parental P388 cells. The accumulation of ACR, however, was moderately reduced in both the resistant cell lines. ACR accumulation in P388/ACR and P388/ADM cells was reduced to respectively 37 and 64% of the level in P388 cells. The amount and the activity of topoisomerase II were comparable in P388 and P388/ACR cells, but they were reduced in P388/ADM cells. Consequently, the formation of protein ( topoisomerase II)- DNA cross-links induced by a topoisomerase II inhibitor was more prominent in the P388 and P388/ACR nuclei than in the P388/ADM nuclei. Notably, ACR could reduce the protein- DNA cross-links equally in the nuclei of P388, P388/ACR, and P388/ADM cells.(ABSTRACT TRUNCATED AT 250 WORDS)
|
Authors | J Dong, M Naito, T Tatsuta, H Seimiya, O Johdo, T Tsuruo |
Journal | Oncology research
(Oncol Res)
Vol. 7
Issue 5
Pg. 245-52
( 1995)
ISSN: 0965-0407 [Print] United States |
PMID | 8534930
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antibiotics, Antineoplastic
- DNA, Neoplasm
- aclacinomycins
- Vincristine
- Etoposide
- Aclarubicin
- Doxorubicin
- Verapamil
- DNA Topoisomerases, Type II
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics)
- Aclarubicin
(analogs & derivatives, pharmacokinetics, pharmacology)
- Animals
- Antibiotics, Antineoplastic
(pharmacokinetics, pharmacology)
- Cell Nucleus
(drug effects, metabolism)
- DNA Topoisomerases, Type II
(metabolism)
- DNA, Neoplasm
(drug effects, metabolism)
- Doxorubicin
(pharmacokinetics, pharmacology)
- Drug Resistance, Multiple
(genetics)
- Drug Resistance, Neoplasm
- Etoposide
(pharmacology)
- Humans
- Immunoblotting
- Leukemia P388
- Tumor Cells, Cultured
- Verapamil
(pharmacology)
- Vincristine
(pharmacology)
|